NCT06586320Enrolling by invitation
Quantification of Parkinson's Disease Patients as a Biomarker for Classification, Prediction and Response to Treatment
Using Mathematical Quantification of Limb and Eye Movements of Parkinson's Disease Patients as a Biomarker for Classification and Prediction of Disease State and Response to Treatment
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
This is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 26 Aug 2024
- Start date
- 6 Feb 2025
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Stardots AB
- Diseases
- Parkinson disease
- NCT number
- NCT06586320
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 6 Feb 2025 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has parkinsonism not due to IPD (drug induced, functional, vascular, etc)
Other illness
- Diagnosed with movement disorder other than IPD or ET that might interfere with hand movements or eye movements (tics, myoclonus, chorea, dystonia, etc)
Age
- Below 18 years of age
Other
- Subjects that meet any of the below criteria will be excluded:
- Not able to sign the informed consent form
- Visual or physical limitations that prevent the subject from performing the baseline eye study requirements
- Being involved in the planning and conduct of the clinical investigation (applies to all sponsor management staff, investigational staff and third-party vendors as applicable)
Who the study is looking for
- For inclusion in the investigation, the subjects must fulfil all the below criteria prior to enrolment:
- Subjects already diagnosed with Idiopathic Parkinson's Disease (IPD)
- or subjects already diagnosed with Essential tremor (ET)
- or subjects who are healthy controls (HC) and are not diagnosed with IPD or ET
- Able to understand and sign the informed consent form.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dartmouth Hitchcock medical center Coordinator of this site? Confirm its status | Manchester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.